fat breakdown) and increasing fat oxidation
The distinction between IM and subcutaneous is unlikely to be clinically meaningful given the absence of human pharmacokinetic benchmarks for either route
Growth hormone-releasing peptides are so poorly studied, we often do not know how they get metabolized in the body and thus which molecules to look for
What feels like 0.25 mg from one vial might feel slightly different from another
Dyspepsia, characterized by upper abdominal discomfort, early satiety, or postprandial fullness, may affect a similar proportion of patients and can contribute to reduced caloric intake and weight loss, though it may also impact quality of life if severe or persistent
The self-sealing rubber stopper is robust, but it's not infallible